Small Molecules
20 June 2016
Mitsubishi Tanabe Pharma Submits New Drug Application for Edaravone to Treat ALS in the United States20 June 2016
Global Blood Therapeutics Announces Initiation of Phase 2a Study of GBT440 in Idiopathic Pulmonary Fibrosis20 June 2016
RedHill Biopharma Announces First Patients Dosed in Phase II Study with BEKINDA™ for IBS-D20 June 2016
Poxel Announces Positive Results From the First Stage of the Ongoing PXL770 Phase 1 Trial20 June 2016
BELLUS Health announces top-line Phase 3 results of KIACTA™ for the treatment of AA amyloidosis18 June 2016
Kura Oncology Doses First Patient in Phase 2 Study of Tipifarnib in Lower Risk Myelodysplastic Syndromes17 June 2016
First Patient Enrolled in Summit’s PhaseOut DMD, a Phase 2 Clinical Trial of Ezutromid in Boys With DMD17 June 2016
Microbion Corporation Announces First Patient Treated in Phase 2a Orthopedic Infection Trial16 June 2016
Zenith Announces Dosing of First Patient in Phase 1 Clinical Trial and Corporate Update Webcast Details16 June 2016
Corbus Pharmaceuticals Announces Last Patient Enrolled in Phase 2 Study of Resunab for Systemic SclerosisNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports